Effects of prostaglandins PGF2a and PGE1 on vascular permeability.
D000818:Animals; D001808:Blood Vessels / Q000187:drug effects / Q000502:physiology; D002056:Burns / Q000188:drug therapy / Q000503:physiopathology; D002244:Carbon; D006632:Histamine / Q000494:pharmacology; D007249:Inflammation / Q000188:drug therapy; D007610:Kallikreins / Q000494:pharmacology; D010539:Permeability; D010998:Pleurisy / Q000139:chemically induced / Q000188:drug therapy; D011453:Prostaglandins / Q000627:therapeutic use; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D014425:Turpentine; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014680:Veins / Q000187:drug effects* / Q000502:physiology
D011453:Prostaglandins; D014662:Vasoconstrictor Agents; D012701:Serotonin; D002244:Carbon; D006632:Histamine; D007610:Kallikreins; D014425:Turpentine